
June 29 (Reuters) – Ipsen will buy U.S.-based Kartos Therapeutics for $450 million to expand its oncology pipeline with a late-stage blood cancer treatment, the French biotech company said on Monday.
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Batman x Samsonite: Iconic DC Super Hero, Reimagined Through the Lens of Modern Travel
Mumbai (Maharashtra) [India], November 16: Samsonite, the global leader in travel, luggage and mobility solutions,…
Pochettino says leaving USMNT will be "tough," leaves open possibility of bringing players to Man U
VIDEO SHOWS: PRESS CONFERENCE WITH USMNT COACH MAURICIO POCHETTINO COMPLETE SHOTLIST AND SCRIPT TO FOLLOW…
Exclusive: Burns & Wilcox to acquire New Orleans MGA and broker Mercury Underwriters
By Mia MacGregor Nov 16 (The Insurer) - Wholesale insurance broker Burns & Wilcox is…